rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

26 Jul,15:29
1386.45
24.05 (1.77%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL
14,006 1,362.40 1,389.70 - 1,360.50 1,409.25 - 748.45 81,232.11
NSE | BSE

Aurobindo Pharma Ltd.

AUROPHARMA

26 Jul,15:59
1386.20
23.40 (1.72%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Aurobindo Pharma Ltd.

BUYSELL
862,019 1362.80 1,389.00 - 1,360.95 1,409.90 - 784.55 1,187,293,249.46

News for Aurobindo Pharma Ltd.

Standard Glass...
Standard Glass Lining IPO: ₹500 Crore Raise, Pharma Focus
Standard Glass Lining Technology, a leading manufacturer of pharma and chemical equipment, files for an IPO seeking ₹500 crore. The IPO includes fresh issuance and an OFS, with proceeds for debt...
Jul 26, 2024 13:08
Aurobindo Pharma...
Aurobindo Pharma Approves Rs 750 Cr Share Buyback
Aurobindo Pharma's board has approved a share buyback plan of up to Rs 750 crore, representing 0.88% of the total paid-up equity share capital. The buyback will be at Rs 1,460 per share.
Jul 18, 2024 14:58
Lupin, Eugia...
Lupin, Eugia Recall Products from US Market: USFDA
Lupin and Eugia, a unit of Aurobindo Pharma, are recalling products from the US market due to manufacturing issues. The USFDA has initiated Class II and Class III recalls for various medications....
Jun 23, 2024 11:22
Aurobindo Pharma...
Aurobindo Pharma Unit Inks Pact with MSD for Biologics Manufacturing
Aurobindo Pharma's TheraNym Biologics has signed a contract with MSD to set up a plant for contract manufacturing operations for biologicals, investing Rs 1,000 crore.
May 31, 2024 20:45
Aurobindo Pharma Q4 Net Profit Up 79.6% to Rs 909 Cr
Aurobindo Pharma's net profit surged 79.6% to Rs 909 crore in the March quarter, driven by strong revenue growth. Read more about the company's financial performance.
May 25, 2024 21:01

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia

News for Pharmaceuticals and health care

Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05
Kargil Vijay...
Kargil Vijay Diwas: India Post Releases Commemorative Stamp
India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.
Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax...
G20 Agrees to Tax Super-Rich, Brazil Leads Effort
Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...
Jul 27, 2024 03:35
Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios
41.57
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,894.03
Face Value (Rs.)
1
Net Profit Margin (%)
9.61
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
6.86

BSE Announcements from Aurobindo Pharma Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 5 day(s) ago
announcement Intimation Of Record Date For Buyback - 18 Jul 2024

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

I am interested in investing 1 Lakh per month in...

My wife is of 31 years age and currently depositing...

Hello Col.I am 34 years old, monthly salary is 1...

Hi, I want to understand about SWP mutual fund...

I was running a bussiness from last seven year with...

More REDIFFGURUS

RediffGurus

Money question

My husband is 50 and I am 47. We have a combined...

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Aurobindo Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close